What’s lifting the MoneyMe (ASX:MME) share price today?

The MoneyMe (ASX:MME) share price is gaining today, up 1.3% in intraday trade. We take a look at MoneyMe’s results for the half year.

| More on:
Deterra share price royalties top asx shares represented by investor kissing piggy bank

Image source: Getty Images

MoneyMe Ltd (ASX: MME) shares are gaining today after the company released its half-year (H1 FY21) financial results. At the time of writing, the MoneyMe share price has edged 1.3% higher to $1.61.

Let’s take a look at how the digital consumer credit business has been performing.

What did MoneyMe report?

The MoneyMe share price is gaining today after the company reported 12% revenue growth for the financial half year ending 31 December. Revenue of $24 million was up from $21 million in H1 FY20. The company said contracted revenue had increased to more than $20 million.

Net profit after tax (NPAT) of $1.3 million was down from $4.3 million in the previous corresponding half, reflecting a $1.1 million income tax benefit in H1 FY21 compared to a $4.3 million tax benefit in the corresponding half.

Statutory profit before tax (PBT) was $200,000, compared to a $1.6 million loss in H1 FY20. Underlying PBT came in at $5.3 million.

In other news boosting the MoneyMe share price, the company reported a 21% growth in originations to $114 million, up from $95 million in the prior corresponding period. Around 47% of customer originations were driven by returning customers.

Customer receivables ramped up by 32% to $168 million.

Commenting on the half-year results, Clayton Howes, MoneyMe CEO, said:

I am delighted with MoneyMe’s profitable growth for the half year ended 31 December 2020 that continues to reflect the increasing diversification of our products and their distribution. It is exciting to see the new funding warehouse facility delivering significantly lower funding costs and new business origination capacity and our core and more recently launched products resonating so well with Generation Now.

Looking ahead, Howes added:

The innovation pipeline is continuing at pace as we continue to invest for massive scale and product diversification opportunities. A fantastic first half that sets the business up well for further high and profitable balance sheet growth.

MoneyMe said it expects revenue and customer receivables growth to accelerate into the second half of the financial year, based on the originations growth reported in Q2 FY21.

MoneyMe share price snapshot

The MoneyMe share price has almost fully recovered from the 69% plunge it faced during the COVID-19-fuelled market panic last February and March. Over the past 12 months, MoneyMe shares are now down 2.4%. That compares to a 0.3% gain on the All Ordinaries Index (ASX: XAO).

So far in 2021, the MoneyMe share price is up 9.5%.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Top 10 ASX 200 shares today
Share Market News

Here are the top 10 ASX shares today

Here are your top 10 biggest gainers in the ASX 200 on Monday.

Read more »

a businessman in a suit tries to forge ahead but is carrying a rope attached to a large anchor that is stuck in the ground against a background of muted sky and barren earth.
Broker Notes

What’s dragging on the Wesfarmers share price on Monday?

We check what one leading broker has to say about the retail giant's prospects.

Read more »

Two medical researchers in white coats collaborate over a computer screen of data in a medical research laboratory
Broker Notes

Where next for the CSL share price?

CSL shares could be heading higher according to one leading broker...

Read more »

Woman on her laptop thinking to herself.
Broker Notes

2 ASX All Ordinaries shares top brokers rate as buys

Here are the latest buy-rated shares from two leading brokers.

Read more »

A woman sits at her computer with hand to mouth and a contemplative smile on her face although she is considering or thinking about information she is seeing on the screen.
Broker Notes

Brokers: 2 ASX 200 shares that could be top buys for growth

Brokers think these ASX 200 shares with growth potential could be leading opportunities.

Read more »

Rede arrow on a stock market chart going down.
Share Fallers

Why the Integrated Research share price is cascading 15% today

Clouds gather around Integrated Research amid latest trading update.

Read more »

Red arrow going down, symbolising a falling share price.
Share Fallers

Why Imugene, Integrated Research, Monash IVF, and Step One shares are sinking

These ASX shares are falling on Monday...

Read more »

blue arrows representing a rising share price ASX 200
Share Market News

Here are the 3 most heavily traded ASX 200 shares on Monday

We take a look at the most traded ASX 200 shares by volume today.

Read more »